Federal contractor · public award history
MAPP BIOPHARMACEUTICAL, INC.
Parent: MAPP BIOPHARMACEUTICAL, INC. Unique Entity Identifier (UEI)M9V9QTHR1H28
- Awards we know about
- 7
- Typical size
- $37.51M
- Middle of their public awards
- Dollars on those awards
- $438.17M
Most of their awards we can see fall roughly between $22.64M and $83.79M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Mar 20, 2027
- Activation date
- Mar 24, 2026
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (7)
Industries & product codes
Award history
- Department of Health and Human Services$28.87MSep 4, 2025Procurement Instrument Identifier (PIID)HHSO100201600021CResearch and Development in the Social Sciences and Humanities541720Health R&D Services; Health Care Services; Applied ResearchAN12Contract awardUSAspending ↗
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
- Department of Health and Human Services$110.88MAug 25, 2025Procurement Instrument Identifier (PIID)75A50122C00076Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
- Department of Health and Human Services$37.51MJul 30, 2025Procurement Instrument Identifier (PIID)75A50119D00018Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Indefinite Delivery Vehicle (IDV)USAspending ↗
MAPP 2019 CONTRACT
- Department of Health and Human Services$184.79MJul 11, 2025Procurement Instrument Identifier (PIID)75A50122C00061Research and Development in Biotechnology (except Nanobiotechnology)541714Drugs And Biologicals6505Contract awardUSAspending ↗
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
- Department of Health and Human Services$3.00MJun 24, 2025Procurement Instrument Identifier (PIID)75A50124C00003Research and Development in Biotechnology (except Nanobiotechnology)541714General Science And Technology R&D Services; General Science And Technology; Basic ResearchAJ11Contract awardUSAspending ↗
DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS
- Department of Health and Human Services$56.70MApr 10, 2025Procurement Instrument Identifier (PIID)75A50118C00024Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
IGF::OT::IGF
- Department of Health and Human Services$16.41MNov 19, 2024Procurement Instrument Identifier (PIID)75A50120C00198Research and Development in Biotechnology (except Nanobiotechnology)541714Drugs And Biologicals6505Contract awardUSAspending ↗
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.